HCV in the Australian primary care setting: real-world effectiveness of 12 weeks of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C

被引：0
|
作者：
O'Loan, Joss [1 ,2 ]
Balcomb, Anne [3 ]
Baker, David [4 ]
Doyle, Joseph [5 ,6 ]
Godfrey, Daniel [7 ]
Kozminsky, Michael [8 ]
Mertens, Michael [9 ]
Vanstraelen, Kim [9 ]
Young, Matt [1 ,2 ]
机构：
[1] Med Clin, Inala, Australia
[2] Kombi Clin, Brisbane, Qld, Australia
[3] Prince St Clin, Orange, NSW, Australia
[4] East Sydney Doctors, Darlinghurst, NSW, Australia
[5] Alfred, Melbourne, Vic, Australia
[6] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia
[7] Gilead Sci Pty Ltd, Melbourne, Vic, Australia
[8] Genesis Med Ctr, Brighton, Australia
[9] Gilead Sci Ltd, London, England
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU419
引用
收藏
页码：S346 / S346
页数：1
相关论文
共 50 条
  • [1] Real-world effectiveness and cost per svr of sofosbuvir/velpatasvir chronic hepatitis c treatment
    Buggisch, Peter
    Atanasov, Petar
    Wursthorn, Karsten
    Stoehr, Albrecht
    Petersen, Joerg
    HEPATOLOGY, 2017, 66 : 856A - 856A
  • [2] Real-world effectiveness and cost per SVR of Sofosbuvir/Velpatasvir chronic hepatitis C treatment
    Buggisch, P.
    Atanasov, P.
    Wursthorn, K.
    Stoehr, A.
    Petersen, J.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S730 - S730
  • [3] EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR IN TREATING HEPATITIS C VIRUS INFECTION IN A REAL-WORLD SETTING
    Wilton, James
    Wong, Stanley
    Yu, Amanda
    Cook, Darrel
    Butt, Zahid Ahmad
    Alvarez, Maria Jose
    Binka, Mawuena
    Darvishian, Maryam
    Yoshida, Eric M.
    Ramji, Alnoor
    Krajden, Mel
    Janjua, Naveed
    HEPATOLOGY, 2019, 70 : 983A - 983A
  • [4] Real-world effectiveness of ledipasvir/sofosbuvir 8 weeks chronic hepatitis C treatment
    Buggisch, Peter
    Wursthorn, Karsten
    Stoehr, Albrecht
    Gauthier, Aline
    Atanasov, Petar K.
    Petersen, Joerg
    HEPATOLOGY, 2015, 62 : 806A - 806A
  • [5] REAL-WORLD EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR 8 WEEKS CHRONIC HEPATITIS C TREATMENT
    Buggisch, P.
    Petersen, J.
    Wursthorn, K.
    Atanasov, P.
    Gauthier, A.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S280 - S280
  • [6] REAL-WORLD EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR 8 WEEKS CHRONIC HEPATITIS C TREATMENT
    Buggisch, P.
    Wursthorn, K.
    Stoehr, A.
    Gauthier, A.
    Atanasov, P. K.
    Petersen, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S811 - S811
  • [7] Real-world effectiveness of ledipasvir/sofosbuvir 8 weeks chronic hepatitis C treatment
    Buggisch, P.
    Wursthorn, K.
    Gauthier, A.
    Atanasov, P.
    Petersen, J.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 24 - 25
  • [8] Real-World Effectiveness of Ledipasvir/Sofosbuvir 8 Weeks Chronic Hepatitis C Treatment
    Buggisch, Peter
    Wursthorn, Karsten
    Gauthier, Aline
    Atanasov, Petar
    Petersen, Joerg
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S869 - S869
  • [9] Real-world effectiveness of Ledipasvir/Sofosbuvir 8 weeks chronic hepatitis C treatment
    Buggisch, P.
    Petersen, J.
    Wursthorn, K.
    Gauthier, A.
    Atanasov, P.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 95 - 96
  • [10] Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings
    Rosati, Silvia
    Wong, Alexander
    Di Marco, Vito
    Perez-Hernandez, Paco
    Macedo, Guilherme
    Brixko, Christian
    Ranieri, Roberto
    Campanale, Francesca
    Bascia, Annalisa
    Fernandez-Rodriguez, Conrado
    de Ledinghen, Victor
    Maida, Ivana
    Teti, Elisabetta
    Mangia, Alessandra
    Vanstraelen, Kim
    Hernandez, Candido
    Mertens, Michael
    Ntalla, Ioanna
    Ramroth, Heribert
    Jimenez, Elena
    FUTURE VIROLOGY, 2022, 17 (07) : 419 - 428
12345